Filtration of platelet concentrates

Area of Science:

• Immunology
• Transfusion Medicine
• Hematology

Background:

• Leukocyte-containing blood products can trigger adverse immune reactions in recipients, including alloimmunization and immunosuppression.
• Alloimmunization is primarily caused by antibodies against major histocompatibility complex (MHC) class I proteins.
• While platelets are targets for HLA antibodies, leukocytes carrying MHC class II proteins are necessary to induce antibody production.

Purpose of the Study:

• To investigate the efficacy of leukocyte filters in reducing leukocyte contamination in platelet concentrates.
• To assess the impact of reduced leukocyte load on the immunogenic potential of blood products.

Main Methods:

• Utilized leukocyte filters with specialized surface modifications.
• Measured the reduction in leukocyte counts in platelet concentrates below the critical immunogenic load of leukocytes (CILL-value).
• Evaluated the reduction in antigenic and immunogenic effects associated with leukocyte contamination.

Main Results:

• Standard platelet concentrates contain over 10^6 leukocytes.
• Leukocyte filters effectively reduce leukocyte numbers in platelet concentrates below the CILL-value.
• This reduction significantly mitigates the antigenic and immunogenic effects of leukocyte contamination.

Conclusions:

• Leukocyte filtration is a crucial method for minimizing immune complications associated with blood transfusions.
• Reducing leukocyte contamination below the CILL-value through filtration substantially lowers the risk of alloimmunization and immunosuppression.
• Leukocyte filters represent an effective strategy in transfusion medicine to improve patient safety.